pH-Triggered Controllable Release of Silver-Indole-3 Acetic Acid Complexes from Mesoporous Silica Nanoparticles (IBN-4) for Effectively Killing Malignant Bacteria

Molecular Pharmaceutics

Volumn 12, Issue 7, 2015, Pages 2289-2304

  Kuthati, Yaswanth ^a   Kankala, Ranjith Kumar ^a   Lin, Shi Xiang ^a   Weng, Ching Feng ^a   Lee, Chia Hung ^a  

^a NATIONAL DONG HWA UNIVERSITY   (Taiwan)

Author keywords

antimicrobial; biofilm; functionalization; hydrazone bonds; Institute of Bioengineering and Nanotechnology 4 (IBN 4) nanoparticles; pH sensitive drug release

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; METAL COMPLEX; NANOCARRIER; NANOCOMPOSITE; NANOCONJUGATE; NANOPARTICLE; REACTIVE OXYGEN METABOLITE; SILICA NANOPARTICLE; SILVER INDOLE 3 ACETIC ACID HYDRAZIDE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; DELAYED RELEASE FORMULATION; HYDRAZONE DERIVATIVE; INDOLEACETIC ACID; INDOLEACETIC ACID DERIVATIVE; METAL NANOPARTICLE; SILICON DIOXIDE; SILVER;

ADULT; AGAR GEL ELECTROPHORESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL INFECTION; CELL ADHESION; CFU COUNTING; COLON CANCER; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG EFFICACY; DRUG RELEASE; DRUG SOLUBILITY; DRUG SYNTHESIS; ESCHERICHIA COLI; FIELD EMISSION SCANNING ELECTRON MICROSCOPY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; HUMAN CELL; IN VIVO STUDY; INFRARED RADIATION; LIMIT OF QUANTITATION; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; NUCLEOPHILICITY; PH; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SOLID STATE; THERMOGRAVIMETRY; TRANSMISSION ELECTRON MICROSCOPY; BACTERIUM; BIOFILM; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG EFFECTS; HT 29 CELL LINE; PHARMACOLOGY; TUMOR CELL LINE;

ANTI-BACTERIAL AGENTS; BACTERIA; BIOFILMS; CELL LINE, TUMOR; DELAYED-ACTION PREPARATIONS; HT29 CELLS; HUMANS; HYDRAZONES; HYDROGEN-ION CONCENTRATION; INDOLEACETIC ACIDS; METAL NANOPARTICLES; SILICON DIOXIDE; SILVER;

EID: 84936760499     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp500836w     Document Type: Article

References (106)

1. Nolte, O. Antimicrobial Resistance in the 21st Century: A Multifaceted Challenge Protein Pept. Lett. 2014, 21 (4) 330-335
2. Giedraitiene, A.; Vitkauskiene, A.; Naginiene, R.; Pavilonis, A. Antibiotic Resistance Mechanisms of Clinically Important Bacteria Medicina (Kaunas, Lithuania) 2011, 47, 137-146
3. Andersson, D. I.; Hughes, D. Persistence of Antibiotic Resistance in Bacterial Populations FEMS Microbiol. Rev. 2011, 35, 901-911
4. Maeda, H. The Enhanced Permeability and Retention (EPR) Effect in Tumor Vasculature: The Key Role of Tumor-Selective Macromolecular Drug Targeting Adv. Enzyme Regul. 2001, 41, 189-207
5. Maeda, H.; Bharate, G. Y.; Daruwalla, J. Polymeric Drugs for Efficient Tumor-Targeted Drug Delivery Based on EPR-Effect Eur. J. Pharm. Biopharm. 2009, 71, 409-419
6. Duncan, R. The Dawning Era of Polymer Therapeutics Nat. Rev. Drug Discovery 2003, 2, 347-360
7. Azzopardi, E. A.; Ferguson, E. L.; Thomas, D. W. The Enhanced Permeability Retention Effect: A New Paradigm for Drug Targeting in Infection J. Antimicrob. Chemother. 2013, 68 (2) 257-274
8. Maeda, H. Vascular Permeability in Cancer and Infection As Related to Macromolecular Drug Delivery, With Emphasis on the EPR Effect for Tumor-Selective Drug Targeting Proc. Jpn. Acad., Ser. B 2012, 88, 53-71
9. Slowing, I. I.; Vivero-Escoto, J. L.; Wu, C.-W.; Lin, V. S. Y. Mesoporous Silica Nanoparticles as Controlled Release Drug Delivery and Gene Transfection Carriers Adv. Drug Delivery Rev. 2008, 60, 1278-1288
10. Gu, J.; Huang, K.; Zhu, X.; Li, Y.; Wei, J.; Zhao, W.; Liu, C.; Shi, J. Sub-150 nm Mesoporous Silica Nanoparticles with Tunable Pore Sizes and Well-Ordered Mesostructure for Protein Encapsulation J. Colloid Interface Sci. 2013, 407, 236-242
11. Slowing, I. I.; Trewyn, B. G.; Giri, S.; Lin, V. S. Y. Mesoporous Silica Nanoparticles for Drug Delivery and Biosensing Applications Adv. Funct. Mater. 2007, 17, 1225-1236
12. Vivero-Escoto, J. L.; Slowing, I. I.; Trewyn, B. G.; Lin, V. S. Y. Mesoporous Silica Nanoparticles for Intracellular Controlled Drug Delivery Small 2010, 6, 1952-1967
13. Manzano, M.; Aina, V.; Areán, C. O.; Balas, F.; Cauda, V.; Colilla, M.; Delgado, M. R.; Vallet-Regí, M. Studies on MCM-41 Mesoporous Silica for Drug Delivery: Effect of Particle Morphology and Amine Functionalization Chem. Eng. J. 2008, 137, 30-37
14. Seleem, M. N.; Munusamy, P.; Ranjan, A.; Alqublan, H.; Pickrell, G.; Sriranganathan, N. Silica-Antibiotic Hybrid Nanoparticles for Targeting Intracellular Pathogens Antimicrob. Agents Chemother. 2009, 53, 4270-4274
15. Edagwa, B. J.; Guo, D.; Puligujja, P.; Chen, H.; McMillan, J.; Liu, X.; Gendelman, H. E.; Narayanasamy, P. Long-Acting Antituberculous Therapeutic Nanoparticles Target Macrophage Endosomes FASEB J. 2014, 28, 5071-5082
16. Clemens, D. L.; Lee, B. Y.; Xue, M.; Thomas, C. R.; Meng, H.; Ferris, D.; Nel, A. E.; Zink, J. I.; Horwitz, M. A. Targeted Intracellular Delivery of Antituberculosis Drugs to Mycobacterium tuberculosis -Infected Macrophages via Functionalized Mesoporous Silica Nanoparticles Antimicrob. Agents Chemother. 2012, 56, 2535-2545
17. Horvati, K.; Bacsa, B.; Kiss, E.; Gyulai, G.; Fodor, K.; Balka, G.; Rusvai, M.; Szabo, E.; Hudecz, F.; Bosze, S. Nanoparticle Encapsulated Lipopeptide Conjugate of Antitubercular Drug Isoniazid: In Vitro Intracellular Activity and in Vivo Efficacy in a Guinea Pig Model of Tuberculosis Bioconjugate Chem. 2014, 25, 2260-2268
18. Yamada, H.; Urata, C.; Ujiie, H.; Yamauchi, Y.; Kuroda, K. Preparation of Aqueous Colloidal Mesostructured and Mesoporous Silica Nanoparticles with Controlled Particle Size in a Very Wide Range from 20 to 700 nm Nanoscale 2013, 5, 6145-6153
19. Colilla, M.; Balas, F.; Manzano, M.; Vallet-Regí, M. Novel Method To Synthesize Ordered Mesoporous Silica with High Surface Areas Solid State Sci. 2008, 10, 408-415
20. Yu, M.; Zhou, L.; Zhang, J.; Yuan, P.; Thorn, P.; Gu, W.; Yu, C. A Simple Approach To Prepare Monodisperse Mesoporous Silica Nanospheres with Adjustable Sizes J. Colloid Interface Sci. 2012, 376, 67-75
21. Li, Z.; Barnes, J. C.; Bosoy, A.; Stoddart, J. F.; Zink, J. I. Mesoporous Silica Nanoparticles in Biomedical Applications Chem. Soc. Rev. 2012, 41, 2590-2605
22. Giraldo, L. F.; López, B. L.; Pérez, L.; Urrego, S.; Sierra, L.; Mesa, M. Mesoporous Silica Applications Macromol. Symp. 2007, 258, 129-141
23. Slowing, I. I.; Vivero-Escoto, J. L.; Wu, C.-W.; Lin, V. S. Y. Mesoporous Silica Nanoparticles as Controlled Release Drug Delivery and Gene Transfection Carriers Adv. Drug Delivery Rev. 2008, 60 (11) 1278-1288
24. Tang, F.; Li, L.; Chen, D. Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility, and Drug Delivery Adv. Mater. 2012, 24 (12) 1504-1534
25. Kuthati, Y.; Sung, P. J.; Weng, C. F.; Mou, C. Y.; Lee, C. H. Functionalization of Mesoporous Silica Nanoparticles for Targeting, Biocompatibility, Combined Cancer Therapies, and Theragnosis J. Nanosci. Nanotechnol. 2013, 13, 2399-2430
26. Friedman, R. Nano Dot Technology Enters Clinical Trials J. Natl. Cancer Inst. 2011, 103, 1428-1429
27. Liu, J.; Harrison, R.; Zhou, J. Z.; Liu, T. T.; Yu, C.; Lu, G. Q.; Qiao, S. Z.; Xu, Z. P. Synthesis of Nanorattles with Layered Double Hydroxide Core and Mesoporous Silica Shell as Delivery Vehicles J. Mater. Chem. 2011, 21, 10641-10644
28. Han, Y.; Ying, J. Y. Generalized Fluorocarbon-Surfactant-Mediated Synthesis of Nanoparticles with Various Mesoporous Structures Angew. Chem., Int. Ed. 2005, 44, 288-292
29. Zhang, L.; Li, Y.; Yu, J. C. Chemical Modification of Inorganic Nanostructures for Targeted and Controlled Drug Delivery in Cancer Treatment J. Mater. Chem. B 2014, 2, 452-470
30. Radovic-Moreno, A. F.; Lu, T. K.; Puscasu, V. A.; Yoon, C. J.; Langer, R.; Farokhzad, O. C. Surface Charge-Switching Polymeric Nanoparticles for Bacterial Cell Wall-Targeted Delivery of Antibiotics ACS Nano 2012, 6, 4279-4287
31. Barbé, C.; Bartlett, J.; Kong, L.; Finnie, K.; Lin, H. Q.; Larkin, M.; Calleja, S.; Bush, A.; Calleja, G. Silica Particles: A Novel Drug-Delivery System Adv. Mater. 2004, 16, 1959-1966
32. He, Q.; Zhang, Z.; Gao, F.; Li, Y.; Shi, J. In Vivo Biodistribution and Urinary Excretion of Mesoporous Silica Nanoparticles: Effects of Particle Size and PEGylation Small 2011, 7, 271-280
33. Fu, C.; Liu, T.; Li, L.; Liu, H.; Chen, D.; Tang, F. The Absorption, Distribution, Excretion, and Toxicity of Mesoporous Silica Nanoparticles in Mice Following Different Exposure Routes Biomaterials 2013, 34, 2565-2575
34. Lu, J.; Liong, M.; Li, Z.; Zink, J. I.; Tamanoi, F. Biocompatibility, Biodistribution, and Drug-Delivery Efficiency of Mesoporous Silica Nanoparticles for Cancer Therapy in Animals Small 2010, 6, 1794-1805
35. Souris, J. S.; Lee, C. H.; Cheng, S. H.; Chen, C. T.; Yang, C. S.; Ho, J. A.; Mou, C. Y.; Lo, L. W. Surface Charge-Mediated Rapid Hepatobiliary Excretion of Mesoporous Silica Nanoparticles Biomaterials 2010, 31, 5564-5574
36. Wang, Y.; Zhao, Q.; Han, N.; Bai, L.; Li, J.; Liu, J.; Che, E.; Hu, L.; Zhang, Q.; Jiang, T.; Wang, S. Mesoporous silica nanoparticles in drug delivery and biomedical applications Nanomedicine (N. Y., NY, U. S.) 2014, 11 (2) 313-327
37. Hu, X.; Hao, X.; Wu, Y.; Zhang, J.; Zhang, X.; Wang, P. C.; Zou, G.; Liang, X. J. Multifunctional Hybrid Silica Nanoparticles for Controlled Doxorubicin Loading and Release with Thermal and pH Dually Response J. Mater. Chem. B 2013, 1, 1109-1118
38. Lu, J.; Choi, E.; Tamanoi, F.; Zink, J. I. Light-Activated Nanoimpeller-Controlled Drug Release in Cancer Cells Small 2008, 4, 421-426
39. Lee, C.-H.; Cheng, S.-H.; Huang, I. P.; Souris, J. S.; Yang, C.-S.; Mou, C.-Y.; Lo, L.-W. Intracellular pH-Responsive Mesoporous Silica Nanoparticles for the Controlled Release of Anticancer Chemotherapeutics Angew. Chem., Int. Ed. 2010, 49, 8214-8219
40. Knezevic, N. Z.; Ruiz-Hernandez, E.; Hennink, W. E.; Vallet-Regi, M. Magnetic Mesoporous Silica-Based Core/Shell Nanoparticles for Biomedical Applications RSC Adv. 2013, 3, 9584-9593
41. Li, X.; Tang, T.; Zhou, Y.; Zhang, Y.; Sun, Y. Applicability of Enzyme-Responsive Mesoporous Silica Supports Capped with Bridged Silsesquioxane for Colon-Specific Drug Delivery Microporous Mesoporous Mater. 2014, 184, 83-89
42. Handke, L. D.; Rogers, K. L.; Olson, M. E.; Somerville, G. A.; Jerrells, T. J.; Rupp, M. E.; Dunman, P. M.; Fey, P. D. Staphylococcus epidermidis saeR Is an Effector of Anaerobic Growth and a Mediator of Acute Inflammation Infect. Immun. 2008, 76, 141-152
43. Fuchs, S.; Pané-Farré, J.; Kohler, C.; Hecker, M.; Engelmann, S. Anaerobic Gene Expression in Staphylococcus aureus J. Bacteriol. 2007, 189, 4275-4289
44. Fallingborg, J.; Christensen, L. A.; Jacobsen, B. A.; Rasmussen, S. N. Very Low Intraluminal Colonic pH in Patients with Active Ulcerative Colitis Dig. Dis. Sci. 1993, 38, 1989-1993
45. Issekutz, A. C.; Bhimji, S. Role for Endotoxin in the Leukocyte Infiltration Accompanying Escherichia coli Inflammation Infect. Immun. 1982, 36, 558-566
46. Bistrian, B. Systemic Response to Inflammation Nutr. Rev. 2007, 65, S170-S172
47. Trevani, A. S.; Andonegui, G.; Giordano, M.; Lopez, D. H.; Gamberale, R.; Minucci, F.; Geffner, J. R. Extracellular Acidification Induces Human Neutrophil Activation J. Immunol. 1999, 162, 4849-4857
48. Dubos, R. The Microenvironment of Inflammation or Metchnikoff Revisited Lancet 1955, 266, xxiv-5
49. Marnell, L.; Mold, C.; Du Clos, T. W. C-Reactive Protein: Ligands, Receptors, and Role in Inflammation Clin. Immunol. 2005, 117, 104-111
50. Coakley, R. J.; Taggart, C.; McElvaney, N. G.; O'Neill, S. J. Cytosolic pH and the Inflammatory Microenvironment Modulate Cell Death in Human Neutrophils after Phagocytosis Blood 2002, 100, 3383-3391
51. Lardner, A. The Effects of Extracellular pH on Immune Function J. Leukocyte Biol. 2001, 69, 522-530
52. Simmen, H. P.; Blaser, J. Analysis of pH and pO2 in Abscesses, Peritoneal Fluid, and Drainage Fluid in the Presence or Absence of Bacterial Infection during and after Abdominal Surgery Am. J. Surg. 1993, 166, 24-27
53. Vermeulen, M.; Giordano, M.; Trevani, A. S.; Sedlik, C.; Gamberale, R.; Fernandez-Calotti, P.; Salamone, G.; Raiden, S.; Sanjurjo, J.; Geffner, J. R. Acidosis Improves Uptake of Antigens and MHC Class I-Restricted Presentation by Dendritic Cells J. Immunol. 2004, 172, 3196-3204
54. Pornpattananangkul, D.; Olson, S.; Aryal, S.; Sartor, M.; Huang, C.-M.; Vecchio, K.; Zhang, L. Stimuli-Responsive Liposome Fusion Mediated by Gold Nanoparticles ACS Nano 2010, 4, 1935-1942
55. Zhuk, I.; Jariwala, F.; Attygalle, A. B.; Wu, Y.; Libera, M. R.; Sukhishvili, S. A. Self-Defensive Layer-by-Layer Films with Bacteria-Triggered Antibiotic Release ACS Nano 2014, 8, 7733-7745
56. Pavlukhina, S.; Lu, Y.; Patimetha, A.; Libera, M.; Sukhishvili, S. Polymer Multilayers with pH-Triggered Release of Antibacterial Agents Biomacromolecules 2010, 11, 3448-3456
57. Xia, X.; Pethe, K.; Kim, R.; Ballell, L.; Barros, D.; Cechetto, J.; Jeon, H.; Kim, K.; Garcia-Bennett, A. Encapsulation of Anti-Tuberculosis Drugs within Mesoporous Silica and Intracellular Antibacterial Activities Nanomaterials 2014, 4, 813-826
58. Yang, D.; Pornpattananangkul, D.; Nakatsuji, T.; Chan, M.; Carson, D.; Huang, C. M.; Zhang, L. The Antimicrobial Activity of Liposomal Lauric Acids against Propionibacterium acnes Biomaterials 2009, 30, 6035-6040
59. Pichavant, L.; Amador, G.; Jacqueline, C.; Brouillaud, B.; Héroguez, V.; Durrieu, M.-C. pH-Controlled Delivery of Gentamicin Sulfate from Orthopedic Devices Preventing Nosocomial Infections J. Controlled Release 2012, 162, 373-381
60. Wang, T.; Wang, M.; Ding, C.; Fu, J. Mono-benzimidazole Functionalized [Small Beta]-Cyclodextrins as Supramolecular Nanovalves for pH-Triggered Release of p-Coumaric Acid Chem. Commun. 2014, 50, 12469-12472
61. Chen, T.; Yu, H.; Yang, N.; Wang, M.; Ding, C.; Fu, J. Graphene Quantum Dot-Capped Mesoporous Silica Nanoparticles through an Acid-Cleavable Acetal Bond for Intracellular Drug Delivery and Imaging J. Mater. Chem. B 2014, 2, 4979-4982
62. Chen, T.; Yang, N.; Fu, J. Controlled Release of Cargo Molecules from Hollow Mesoporous Silica Nanoparticles Based on Acid and Base Dual-Responsive Cucurbit[7]uril Pseudorotaxanes Chem. Commun. 2013, 49, 6555-6557
63. Wang, M.; Chen, T.; Ding, C.; Fu, J. Mechanized Silica Nanoparticles Based on Reversible Bistable [2]Pseudorotaxanes as Supramolecular Nanovalves for Multistage pH-Controlled Release Chem. Commun. 2014, 50, 5068-5071
64. Mudakavi, R. J.; Raichur, A. M.; Chakravortty, D. Lipid Coated Mesoporous Silica Nanoparticles As an Oral Delivery System for Targeting and Treatment of Intravacuolar Salmonella infections RSC Adv. 2014, 4, 61160-61166
65. Ambrogi, V.; Donnadio, A.; Pietrella, D.; Latterini, L.; Proietti, F. A.; Marmottini, F.; Padeletti, G.; Kaciulis, S.; Giovagnoli, S.; Ricci, M. Chitosan Films Containing Mesoporous SBA-15 Supported Silver Nanoparticles for Wound Dressing J. Mater. Chem. B 2014, 2, 6054-6063
66. Ahmed, A.; Hearn, J.; Abdelmagid, W.; Zhang, H. Dual-Tuned Drug Release by Nanofibrous Scaffolds of Chitosan and Mesoporous Silica Microspheres J. Mater. Chem. 2012, 22, 25027-25035
67. Lin, L.; Zhang, H.; Cui, H.; Xu, M.; Cao, S.; Zheng, G.; Dong, M. Preparation and Antibacterial Activities of Hollow Silica-Ag Spheres Colloids Surf., B 2013, 101, 97-100
68. Fang, W.; Ma, L.; Zheng, J.; Chen, C. Fabrication of Silver-Loaded Hollow Mesoporous Aluminosilica Nanoparticles and Their Antibacterial Activity J. Mater. Sci. 2014, 49, 3407-3413
69. Liong, M.; France, B.; Bradley, K. A.; Zink, J. I. Antimicrobial Activity of Silver Nanocrystals Encapsulated in Mesoporous Silica Nanoparticles Adv. Mater. 2009, 21, 1684-1689
70. Tian, Y.; Qi, J.; Zhang, W.; Cai, Q.; Jiang, X. Facile, One-Pot Synthesis, And Antibacterial Activity of Mesoporous Silica Nanoparticles Decorated with Well-Dispersed Silver Nanoparticles ACS Appl. Mater. Interfaces 2014, 6, 12038-12045
71. Liu, T.; Song, X.; Guo, Z.; Dong, Y.; Guo, N.; Chang, X. Prolonged Antibacterial Effect of Silver Nanocomposites with Different Structures Colloids Surf., B 2014, 116, 793-796
72. Wang, L.; He, H.; Zhang, C.; Sun, L.; Liu, S.; Yue, R. Excellent Antimicrobial Properties of Silver-Loaded Mesoporous Silica SBA-15 J. Appl. Microbiol. 2014, 116, 1106-1118
73. Xu, K.; Wang, J.-X.; Kang, X.-L.; Chen, J.-F. Fabrication of Antibacterial Monodispersed Ag-SiO2 Core-Shell Nanoparticles with High Concentration Mater. Lett. 2009, 63, 31-33
74. Zhang, X.; Niu, H.; Yan, J.; Cai, Y. Immobilizing Silver Nanoparticles onto the Surface of Magnetic Silica Composite to Prepare Magnetic Disinfectant with Enhanced Stability and Antibacterial Activity Colloids Surf., A 2011, 375, 186-192
75. Capeletti, L. B.; de Oliveira, L. F.; Goncalves Kde, A.; de Oliveira, J. F.; Saito, A.; Kobarg, J.; dos Santos, J. H.; Cardoso, M. B. Tailored Silica-Antibiotic Nanoparticles: Overcoming Bacterial Resistance with Low Cytotoxicity Langmuir 2014, 30, 7456-7464
76. Qi, G.; Li, L.; Yu, F.; Wang, H. Vancomycin-Modified Mesoporous Silica Nanoparticles for Selective Recognition and Killing of Pathogenic Gram-Positive Bacteria over Macrophage-like Cells ACS Appl. Mater. Interfaces 2013, 5, 10874-10881
77. Li, L.-L.; Wang, H. Antibacterial Agents: Enzyme-Coated Mesoporous Silica Nanoparticles as Efficient Antibacterial Agents in Vivo Adv. Healthcare Mater. 2013, 2, 1298-1298
78. Monzillo, V.; Dalla Valle, C.; Corbella, M.; Percivalle, E.; Sassera, D.; Scevola, D.; Marone, P. Antibacterial Activity and Cytotoxic Effect of SIAB-GV3 New Microbiol. 2014, 37, 535-541
79. Yazdi, I. K.; Murphy, M. B.; Loo, C.; Liu, X.; Ferrari, M.; Weiner, B. K.; Tasciotti, E. Cefazolin-Loaded Mesoporous Silicon Microparticles Show Sustained Bactericidal Effect against Staphylococcus aureus J. Tissue Eng. 2014, 5 No. 2041731414536573
80. Xiu, Z.-M.; Zhang, Q.-B.; Puppala, H. L.; Colvin, V. L.; Alvarez, P. J. J. Negligible Particle-Specific Antibacterial Activity of Silver Nanoparticles Nano Lett. 2012, 12, 4271-4275
81. Liu, J.; Sonshine, D. A.; Shervani, S.; Hurt, R. H. Controlled Release of Biologically Active Silver from Nanosilver Surfaces ACS Nano 2010, 4, 6903-6913
82. Ocwieja, M.; Adamczyk, Z. Controlled Release of Silver Nanoparticles from Monolayers Deposited on PAH Covered Mica Langmuir 2013, 29 (11) 3546-3555
83. Dlugosz, M.; Bulwan, M.; Kania, G.; Nowakowska, M.; Zapotoczny, S. Hybrid Calcium Carbonate/Polymer Microparticles Containing Silver Nanoparticles As Antibacterial Agents J. Nanopart. Res. 2012, 14, 1313
84. Furno, F.; Morley, K. S.; Wong, B.; Sharp, B. L.; Arnold, P. L.; Howdle, S. M.; Bayston, R.; Brown, P. D.; Winship, P. D.; Reid, H. J. Silver Nanoparticles and Polymeric Medical Devices: A New Approach to Prevention of Infection? J. Antimicrob. Chemother. 2004, 54, 1019-1024
85. Burke, A. M.; Hanrahan, J. P.; Healy, D. A.; Sodeau, J. R.; Holmes, J. D.; Morris, M. A. Large Pore Bifunctionalized Mesoporous Silica for Metal Ion Pollution Treatment J. Hazard. Mater. 2009, 164, 229-234
86. Li, J.; Miao, X.; Hao, Y.; Zhao, J.; Sun, X.; Wang, L. Synthesis, Amino-Functionalization of Mesoporous Silica, and Its Adsorption of Cr(VI) J. Colloid Interface Sci. 2008, 318, 309-314
87. Mureseanu, M.; Reiss, A.; Stefanescu, I.; David, E.; Parvulescu, V.; Renard, G.; Hulea, V. Modified SBA-15 Mesoporous Silica for Heavy Metal Ions Remediation Chemosphere 2008, 73, 1499-1504
88. Chaves, M. R.; Dockal, E. R.; Souza, R. C.; Buchler, P. M. Biogenic Modified Silica As a Sorbent of Cadmium Ions: Preparation and Characterization Environ. Technol. 2009, 30, 663-671
89. Ros-Lis, J. V.; Casasus, R.; Comes, M.; Coll, C.; Marcos, M. D.; Martinez-Manez, R.; Sancenon, F.; Soto, J.; Amoros, P.; El Haskouri, J.; Garro, N.; Rurack, K. A Mesoporous 3D Hybrid Material with Dual Functionality for Hg2+ Detection and Adsorption Chem.-Eur. J. 2008, 14, 8267-8278
90. Andersen, K. B.; von Meyenburg, K. Are Growth Rates of Escherichia coli in Batch Cultures Limited by Respiration? J. Bacteriol. 1980, 144, 114-123
91. Smith, A. J.; Jackson, M. S.; Bagg, J. The Ecology of Staphylococcus Species in the Oral Cavity J. Med. Microbiol. 2001, 50, 940-946
92. Otto, M. Staphylococcus epidermidis-The "Accidental" Pathogen Nat. Rev. Microbiol. 2009, 7, 555-567
93. Beloin, C.; Roux, A.; Ghigo, J. M. Escherichia coli Biofilms. In Bacterial Biofilms; Romeo, T., Ed.; Springer: Berlin Heidelberg, 2008; Vol. 322, pp 249-289.
94. Kang, C. I.; Song, J. H. Antimicrobial Resistance in Asia: Current Epidemiology and Clinical Implications Infect. Chemother. 2013, 45, 22-31
95. Tenney, J. H.; Moody, M. R.; Newman, K. A.; Schimpff, S. C.; Wade, J. C.; Costerton, J. W.; Reed, W. P. Adherent Microorganisms on Lumenal Surfaces of Long-Term Intravenous Catheters. Importance of Staphylococcus epidermidis in Patients with Cancer Arch. Intern. Med. 1986, 146, 1949-1954
96. Bridier, A.; Sanchez-Vizuete Mdel, P.; Le Coq, D.; Aymerich, S.; Meylheuc, T.; Maillard, J. Y.; Thomas, V.; Dubois-Brissonnet, F.; Briandet, R. Biofilms of a Bacillus subtilis Hospital Isolate Protect Staphylococcus aureus from Biocide Action PLoS One 2012, 7, e44506
97. Hedin, G. Staphylococcus epidermidis-Hospital Epidemiology and the Detection of Methicillin Resistance Scand. J. Infect. Dis., Suppl. 1993, 90, 1-59
98. Ostrowska, K.; Strzelczyk, A.; Rozalski, A.; Staczek, P. Bacterial Biofilm As a Cause of Urinary Tract Infection-Pathogens, Methods of Prevention, and Eradication Postepy Hig. Med. Dosw. 2013, 67, 1027-1033
99. Ariano, R. E.; Franczuk, C.; Fine, A.; Harding, G. K.; Zelenitsky, S. A. Challenging the Current Treatment Paradigm for Methicillin-Resistant Staphylococcus epidermidis Peritonitis in Peritoneal Dialysis Patients Peritoneal Dial. Int. 2002, 22, 335-338
100. O'Gara, J. P.; Humphreys, H. Staphylococcus epidermidis Biofilms: Importance and Implications J. Med. Microbiol. 2001, 50, 582-587
101. Sondi, I.; Salopek-Sondi, B. Silver Nanoparticles As Antimicrobial Agent: A Case Study on E. coli as a Model for Gram-Negative Bacteria J. Colloid Interface Sci. 2004, 275, 177-182
102. Gilbert, P.; Maira-Litran, T.; McBain, A. J.; Rickard, A. H.; Whyte, F. W. The Physiology and Collective Recalcitrance of Microbial Biofilm Communities Adv. Microbiol. Physiol. 2002, 46, 202-256
103. Keren, I.; Shah, D.; Spoering, A.; Kaldalu, N.; Lewis, K. Specialized Persister Cells and the Mechanism of Multidrug Tolerance in Escherichia coli J. Bacteriol. 2004, 186, 8172-8180
104. Lewis, K. Persister Cells and the Riddle of Biofilm Survival Biochem. Biokhimiia 2005, 70, 267-274
105. Roberts, M. E.; Stewart, P. S. Modelling Protection from Antimicrobial Agents in Biofilms through the Formation of Persister Cells Microbiology (Reading, England) 2005, 151, 75-80
106. Zhou, J.; Guo, A.; Qi, X. Cell Envelope Disruption of E. coli Exposed to ε-Polylysine by FESEM and TEM Technology Scanning 2013, 35 (6) 412-417